Welcome to our dedicated page for Gbt Technologies news (Ticker: GTCH), a resource for investors and traders seeking the latest updates and insights on Gbt Technologies stock.
GBT Technologies Inc. reports developments in artificial intelligence, Internet of Things and intelligent platform technologies through its OTC Pink-traded public-company updates. Recent company news centers on wholly owned subsidiaries that extend its platform into automated wellness retail and digital media.
Recurring themes include Cube Wellness Technologies, which deploys AI-enabled smart wellness machines for university, workplace and community environments, and Cube X Media Corporation, which creates digital advertising, vertical video and cinematic content for distribution across interactive machine networks. Updates also cover subsidiary formation, leadership and board appointments, material agreements, capital-structure matters and operating results.
GBT Technologies Inc. (GTCH) announced updates regarding its intellectual property (IP) portfolio, emphasizing its focus on research and development. The company now holds 14 patents and has submitted 25 new applications across various technology domains, including AI, cybersecurity, and healthcare. In Q1 2023, GBT achieved a 12.5% growth in its IP portfolio, adding four approved patents. The core AI technology, AVANT! AI™, has been trademarked and is available for licensing. Additionally, GBT signed a letter of intent with Bannix Acquisition Corp to license its Apollo technology for enhancing safety in autonomous vehicles. The company remains optimistic about future growth, highlighting established partnerships and advancing its IP portfolio.
GBT Technologies Inc. (OTC PINK: GTCH) announced the upcoming granting of U.S. patent number 11,638,523 for its AI-driven health monitoring device, qTerm, on May 2, 2023. This patent protects a sophisticated technology for measuring vital signs like body temperature, blood oxygen, and heart rate with a finger touch. The device, developed in 2022, includes mobile and web applications for data tracking and remote telemedicine capabilities. GBT aims to enhance qTerm with future releases featuring blood pressure monitoring and advanced AI analytics. A continuation patent will also be filed to strengthen its intellectual property. This development reflects GBT's commitment to creating innovative health tech solutions.
GBT Technologies Inc. (OTC PINK: GTCH) has received a notice of allowance from the USPTO for its continuation application regarding a secured mobile database management system. This technology aims to enhance database communication through a private protocol, improving the processing of database objects. The continuation application broadens the original patent's scope, which was granted on December 1, 2020. It focuses on innovative methods for sharing and managing databases via mobile devices using a proprietary Integrated Circuit (IC). The system allows real-time data restoration from globally distributed mobile devices, with a central backup server for immediate access. The continuation patent is expected to be granted in the coming months, strengthening GBT’s intellectual property portfolio in the IoT and mobile technology sectors.
GBT Technologies Inc. (OTC PINK: GTCH) has announced an Asset Purchase Agreement with Trend Innovation Holdings, Inc. (TREN) concerning the sale of its proprietary text-generation system, Avant! AI. This deep learning model utilizes machine learning and natural language processing to enhance user interaction with devices. GBT retains a perpetual license for internal development purposes while providing technical support to TREN for the system's implementation.
The agreement aligns with GBT's focus on developing a comprehensive technology IP portfolio, including patents and prototypes. The CEO, Mansour Khatib, stated that selling Avant! AI while retaining a license strengthens GBT's position as an intellectual property company. Further updates regarding GBT's IP technology portfolio are expected in a future press release.
The patent for GBT Technologies’ 3D, Multi-Planar IC design was granted on March 7, 2023, strengthening its position in the semiconductor industry. The innovative architecture aims to significantly reduce silicon usage in integrated circuits, enhancing performance and lowering costs. The technology is critical as South Korea invests heavily in semiconductor R&D, making it a key player globally. GBT plans ongoing R&D to advance its microchip technology, seeking partnerships for commercialization. This positions GBT favorably as the demand for efficient semiconductor solutions increases.
GBT Technologies Inc. (OTC PINK: GTCH) recently announced that its patent application for predictive, three-dimensional, multi-planar semiconductor designs has been granted Fast Track processing by the USPTO. This program aims to expedite IP protection, allowing GBT to secure patents within approximately twelve months. The technology is designed to optimize integrated circuit manufacturing by determining the best 3D shapes for performance and efficiency. GBT plans to file additional patents in this innovative field, emphasizing its commitment to advancing semiconductor architecture.
GBT Technologies Inc. (OTC PINK: GTCH) filed a continuation patent application for technology aimed at correcting electrical connectivity mismatches in integrated circuits (ICs), enhancing design efficiency for microchips of 5nm and below. The patented system utilizes algorithmic methods to automate corrections, significantly reducing design time and improving performance. Additionally, GBT filed a continuation-in-part (CIP) patent for new developments in photonic integrated circuit (PIC) architecture, targeting high efficiency and bandwidth. However, successful implementation requires adequate capital and strategic partnerships, indicating potential challenges for future development.
GBT Technologies Inc. (GTCH) announced that its non-provisional patent application for the qTerm AI-driven human vitals device has received a notice of allowance, with the patent expected to be granted soon. The device, designed to measure human vitals such as body temperature, blood oxygen, and heart rate through a user-friendly interface, aims to revolutionize personal healthcare and telemedicine. Accompanied by a mobile app and web application, qTerm will allow users to access their health data remotely. However, the company acknowledges potential challenges in raising capital and establishing partnerships for production and distribution.
GBT Technologies Inc. (OTC PINK: GTCH) announced the filing of a federal trademark application for its Avant! AI technology, submitted on March 1, 2023, with the USPTO (serial number 97817437). Avant! AI utilizes natural language processing (NLP) and machine learning for enhanced user interactions in various fields, including medicine and cybersecurity. Tokenize, its partially owned subsidiary, aims to improve Avant! AI's dialog interface before its web application release later this year. GBT emphasizes its commitment to developing advanced AI solutions, following prior successes with derivative applications like Hippocrates, which provides health-related recommendations.
GBT Technologies Inc. (OTC PINK: GTCH) is advancing its Avant! AI technology through GBT Tokenize LLC to enhance cybersecurity threat modeling. GBT holds a 50% stake in GBT Tokenize, which aims to train Avant! for identifying security vulnerabilities in applications. This initiative focuses on minimizing risks of data breaches and cyberattacks, while ensuring compliance with industry standards like PCI DSS, GDPR, and HIPAA. The technology is designed to analyze both structured and unstructured data, enabling real-time threat identification and remediation to protect sensitive information.